A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas
โ Scribed by J. Russell Geyer; Clinton F. Stewart; Mehmet Kocak; Alberto Broniscer; Peter Phillips; James G. Douglas; Susan M. Blaney; Roger J. Packer; Sri Gururangan; Anu Banerjee; Mark W. Kieran; Larry E. Kun; Richard J. Gilbertson; James M. Boyett
- Book ID
- 116430470
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 291 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. Prognosis for the majority of children with brain stem gliomas is dismal. In previous studies, recombinant beta-interferon (@IF) has been shown to be effective for children with recurrent brain stem gliomas and may also act synergistically with radiotherapy (RT). ## METHODS. Thir
## Abstract ## BACKGROUND Ninety percent of children with diffuse, intrinsic brainstem tumors will die within 18 months of diagnosis. Radiotherapy is of transient benefit to these children, and a potential way to improve its efficacy is to add radiosensitizers. Carboplatin is antineoplastic and ra
## Background: Diffuse pontine gliomas remain one of the most lethal of pediatric malignancies despite the use of increasingly intensive therapies. we delivered intensive chemotherapy during and following 70.2 gy of hyperfractionated radiation therapy in an attempt to improve survival. ## Procedur